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We previously reported that normal human keratinocytes 
express muscarinic receptors, and that acetylcholine induces 
attachment of these cells to each other. We have now studied 
the ability of human keratinocytes to synthesize, secrete, and 
degrade acetylcholine. To detect and localize the synthesiz-
ing enzyme choline acetyl transferase and degrading enzyme 
acetylcholinesterase, cultured cells and ctyostat sections of 
normal human skin were pre-incubated with specific mono-
clonal antibodies and stained with an avidin-biotin complex/ 
alkaline phosphatase. The choline acetyl transferase activity 
was assessed by the conversion of[3H]acetyl CoA to [3H]ace-
tylcholine, and newly synthesized [3H]acetylcholine was de-
tected using thin-layer chromatography. The acetylcholin-
esterase activity was measured spectrophotometrically. Both 
cholinergic enzymes were present in cultured keratinocytes, 
and in basal, spinous and granular epidermal cell layers. Cho-
line acetyltransferase was visualized in the vicinity of cell 
W e previously reported high-density muscarinic acetylcholine receptors (rnAChR) on the cell surfaces of intact human keratinocytes, and the ability of muscarinic ligands to regulate adhesion and motility of these cells [1] . Ace-
tylcholine (~Ch) antagonized acantholysis induced by pemphigus 
antibodies irl lIitro, and restored confluence of keratinocyte mono-
layers altered by the serine proteinase trypsin, and the calcium che-
lator ethylenediaminetetraacetic acid. The muscarinic antagonist 
atropine produced cell-cell detachment (acantholysis) in a dose-de-
pendent manner. Because these atropine-treated acantholytic kerati-
nocytes re-attached to each other spontaneously, we hypothesized 
that ACh might be synthesized by these cells, and that it is endoge-
nous ACh that eventually reverses the effects of added atropine. We 
tested this hypothesis and found that human keratinocytes synthe-
size, store, secrete, and degrade ACh. Herein, we demonstrate locali-
zation and activities of keratinocyte cholinergic enzymes choline 
acetyltransferase (ChAT) that synthesizes ACh, and acetylcholines-
terase (AChE) that degrades ACh, as well as the rates of ACh synthe-
sis and release by human keratinocytes in cell culture. 
Manuscript received October 29, 1992; accepted for publication March 
15,1993. 
Presented at the 1992 Regional Meeting of the Society for Investigative 
Dermatology, Chicago, Illinois 11/05/92, and published in the form of an 
abstract (Clin Res 40:708A, 1992). 
Reprint request to: Dr. Sergei A. Grando, Department of Dermatology, 
P.O. Box 98 UMHC, Minneapolis, Minnesota 55455-0392. 
Abbreviations: AcCoA, acetyl coenzyme A; ACh, acetylcholine; AChE, 
acetylcholinesterase; ChAT, choline acetyl transferase; KRB, Krebs-Ringer 
bicarbonate buffer; mAChR, muscarinic acetylcholine receptors. 
nuclei, and acetylcholinesterase was observed in or near cell 
membranes. Newly synthesized acetylcholine was detected 
in both cell homogenates and culture supernatants. The esti-
mated Vmax of the synthesis of labeled acetylcholine by \ 
homogenized keratinocytes was about 20 pmoles acetylcho-
line produced/mg protein/min at 37"C. A single keratino-
cyte synthesized a mean of 2 X 10- 17 moles, and released 
7 X 10- 19 moles a.cetylcholine per minute. Both cell homo-
genates and culture supernatants exhibited similar acetylcho-
linesterase activities indicating that human keratinocytes se- I 
crete acetylcholinesterase, too . Thus, we have demonstrated 
that normal human keratinocytes possess choline acetyl-
transferase and acetylcholinesterase, and synthesize, store, 
release, and degrade acetylcholine. Because human keratino-
cytes can also respond to acetylcholine, we believe that kerati-
nocyte acetylcholine works in the epidermis as a local hor-
mone.] Invest Dermatoll01 :32 -36, 1993 
MATERIALS AND METHODS 
\ 
Human Keratinocyte Cultures Keratinocytes were obtained 
from normal humall neonatal foreskins. Specimens freed from fat \ 
and clotted blood were rinsed in Ca++ - and Mg++ -free phosphate-
buffered saline (Gibeo, Grand Island, NY) and placed epidermis up 
into 35-mm petri dishes (Falcon 3001, Becton Dickinson Labware, 
Lincoln Park, NJ) containing Dulbecco's modified Eagle's medium 
(DMEM; Biologos, Inc, Naperville, IL) supplemented to contain 
0.125% trypsin, 10 ,ugjml gentamicin, and 5 ,ugjml fungizone 
(Gibco). After overnight incubation at 37"C in a humidified atmo-
sphere with 5% CO2 , epidermis was separated from dermis and 
individual keratinocytes were released by rapid pipetting. The cells 
were resuspended in DMEM sUfplemented to contain 20% pooled 
decomplemented newborn cal serum (Biologos; DMEM-NCS) 
and centrifuged for 10 min at 200 X g. The pellet was resuspended 
in keratinocyte growth medium (KGM) containing 5 ngjml recom-
binant epidermal growtb factor and 50 ,ugjml bovine pituitary ex-
tract (all from Gibco) and grown in 75-cm2 Falcon tissue culture 
flasks (T -flasks) at 37°C in 5% CO2 , The concentration of calcium 
in KGM was 0.09 mM. The medium was cbanged every 3 d until 
keratinocytes covered two thirds of the flask bottom. The cells were 
released from the T-flasks by a 2-min incubation in trypsin 
(0.05%) -ethylenediaminetetraacetic acid (0.02%) solution (Biolo-
gos), centrifuged for 10 min at 200 X g in DMEM-NCS, resus-
pended in KGM, and inoculated into new T-flasks for further 
growth. After two passages, the keratinocytes were used in experi-
ments. \ 
The purity of human keratinocyte cultures {greater than 95%} 
was confirmed immu.nocytochemically using DAKO-CK monoelo· 
nal mouse anti-human cytokeratin antibodies {MNF 116, Dako· 
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patts, Carpinteria, CA). The trypan blue dye exclusion test revealed 
not less than 95% living cells in all keratinocyte cultures. 
Immunohistochemical Assays Immunohistochemical proce-
dures were performed in keratinocyte monolayers, and in frozen 
sections of normal human epidermis obtained from cosmetic surgi-
cal procedures. For immunocytochemistry, 2.5 X 7.5 em speci-
mens were cut out from keratinocyte monolayers (75 - 80% con-
fluence) growing on the bottom of plastic 75-cm2 Falcon 
tissue-culture flasks . The cutouts were rinsed with 0.05 M Tris-
buffered saline (TBS) to remove KGM, incubated for 10 min in 
65% ~cetone to permea~iliz~ cell membran~s, placed ~n TBS for.5 
min, mcubated for 20 111m WIth normal rabbIt serum dIluted 1 : 5 In 
TBS for blocking of non-specific binding, and then incubated for 
30 min at room temperature with either anti-ChAT (MAB305) 
or anti-AChE (MAB303) mouse IgG 1 monoclonal antibodies 
(MoAbs) (Chemicon International, Temecula, CA) diluted in TBS 
1: 50 or 1: 10, respectively. Following incubation, the specimens 
were stained with avidin-biotin complex/alkaline phosphatase 
(DAKO K 376; Dakopatts) [2]. Some specimens were counter-
stained with Mayer's hematoxylin to highlight morphology. Cryo-
stat sections of normal human skin were fixed in 100% acetone for 
10 min, and then treated with MoAbs as above. Negative controls 
included omitting of the first layer monoclonal antibodies and re-
placing it with i) normal rabbit serum and ii) the isotype matching 
anti-CD3 MoAbs (M 756, Dakopatts). 
Assays of ChAT Activity Three million viable keratinocytes, 
released from 752-cm tissue culture flasks by 2-min incubation in 
trypsin/ethylenediaminetetraacetic acid, were rinsed in DMEM-
NCS and washed in Krebs-Ringer bicarbonate buffer (KRB; Sigma, 
St. Louis, MO). Cells were resuspended in 3.5 ml KRB containing 
145 mM NaCI, 5 mM KCI, 1.2 mM CaCI2, 1.3 mM MgCI2' 
2 mM sodium-phosphate/l0 mM Tris-HCI buffer, pH 7.4, and 
10 mM glucose, put on ice, and disrupted by sonication. The pro-
tein concentration in keratinocyte homogenates was determined 
using the Micro BCA kit (Pierce, Rockford, IL). Experimental vials 
received 0.5 ml cell homogenate, and control vials received 0.5 ml 
KRB (blank). To each vial, 0.5 ml incubation buffer, consisting of 
50 mM Tris-HCI (pH 8.0) with 1 mM acetyl coenzyme A 
(AcCoA), 10 mM choline, 1 mM eserine (all from Sigma), and 
0.02 mM [lH1AcCoA (0.2 Ci/mmol; NEN, Boston, MA), were 
added. The assay was performed in the presence of saturating con-
centrations of non-labeled AcCoA and choline (determined in the 
standardization of the assay) to estimate the kinetics of [lH1ACh 
synthesis by putative keratinocyte ChAT. Eserine (i.e., physostig-
mine; the specific inhibitor of AChE) was included in the incuba-
tion buffer to protect newly synthesized [lH)ACh from enzymatic 
degradation by putative keratinocyte AChE. Vials were capped, 
vortexed, and incubated in a CO2 incubator at 3 r C for 20 min. 
After incubation, 5.0 ml of freshly prepared scintillation cocktail, 
consisting of nine parts INSTA-FLUOR (Packard Instrument Co., 
Inc, Downers Grove, IL) and one part tetraphenylboron (Sigma) in 
n-butanol, were added to each vial, and the newly synthesized 
[3H)ACh was extracted from the aqueous phase [3). To calculate 
ChAT activity, blank values were subtracted from experimental 
values, and the obtained differential of disintegrations per minute 
(dpm) was converted into the amount of ACh produced by mg 
protein per min. 
To determine the release of ACh, 3 X 106 keratinocytes in KGM 
were inoculated into 75-cm2 tissue culture flasks, and the flasks 
were incubated overnight to assure complete settling of the cells 
(confirmed by phase-contrast microscopy) . Then, the monolayers 
were washed with prewarmed (37°C) KRB, fed with 7.0 ml incu-
bation buffer/KRB (1: 1 [v Iv)), and incubated for 1 h in a CO2 
incubator, after which 1.0 ml aliquots of the supernatant (chasing 
medium) were added to scintillation vials to extract PH]ACh. Blank 
value vials contained 1.0 ml incubation buffer/KRB instead of 
chasing medium. 
To estimate the rates of ACh synthesis and release, the differen-
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tial dpm were converted into the mean amount of ACh produced or 
released by a single cell per min. 
Newly synthesized [lH)ACh in keratinocyte homogenates and 
chasing media was also detected by thin-layer chromatography 
(TLC) [4) onl0 X 20 cm silica Gel GF plates (Analtech, Inc, New-
ark, DE) using [3H]AcCoA, and [lH]ACh (90.0 mCi/mmol; NEN) 
as external standards and butanol: ethanol: acetic acid: water 
(8: 2: 1 : 3) as solvent system. After a 5-h run, the plates were dried, 
and 1.0 X 0.25 cm pieces of silica were scratched from the plates 
and transferred into scintillation vials containing 0.7 ml 0.5 M ace-
tic acid to extract radioactivity. After shaking the vials, each of them 
received 6.0 ml of the scintillation cocktail Aquasol, and the radioac-
tivity was measured in the LKB liquid scintillation counter. 
As another control, 10 U AChE (Sigma) were added instead of 
eserine to some cell homogenate-, and chasing medium-
containing samples, and to some samples containing authentic 
(lH)ACh. 
Assay of AChE Activity Pre-confluent keratinocyte cultures 
were incubated with 5.0 ml KRB overnight at 37°C in a CO2 
incubator. Supernatants were collected and immediately used in the 
AChE assay. The flasks were washed with fresh KRB, and keratino-
cytes were scraped from the flasks with a rubber policeman. The 
cells were resuspended in 5.0 ml ice-cold KRB, put on ice, and 
disrupted by sonication. The protein concentration was measured 
using the Micro BCA kit. The AChE activity was immediately 
assessed spectrophotometrically by measuring the optical density at 
412 nm of a solution containing acetylthiocholine iodide as a sub-
strate and dithiobisnitrobenzoic acid as a reagent that yields a yellow 
color in the presence of thiocholine [5]. The optical density was 
measured each min at room temperature in both experimental and 
control samples. Experimental samples contained 0.5 ml keratino-
cyte homogenate or culture supernatant, 20.0 J.lI of 0.075 M sub-
strate, and 100.0,u1 of 0.01 M reagent in 0.1 M phosphate buffer, 
pH 8.0 (total volume 3.0 ml). Control samples contained only the 
substrate, reagent, and buffer in the same total volume. After 15 
min, the optical density increment of control samples (non-enzy-
matic hydrolysis of the substrate) was subtracted from that of experi-
mental samples, and the rates of enzymatic hydrolysis were con-
verted into absolute units. One unit (U) of AChE activity 
hydrolyzed 1 J.lmole of substrate to thiocholine and acetate per min 
at pH 8.0 and 25°C. 
The specificity of the assay was confirmed in another set of ex-
periments in which keratinocyte cultures were incubated in the 
presence of 0.5 mM eserine. 
Statistics All experiments were performed in triplicate, or qua-
druplicate, and the results were expressed as mean ± SD. Signifi-
cance was determined using the Student t test. Results were deemed 
significant if the calculated p value was less than 0.05. 
RESULTS 
Immunolocalization of ChAT and AChE in Human Kerat-
inocytes Both keratinocyte cultures and frozen sections of 
human epidermis contained ChAT. In the monolayers comprised of 
non-differentiated basal cells, ChAT immunoreactivity was con-
fined to the perinuclear area of the cell cytoplasm (Fig la). In epider-
mis, cells in the basal, spinous, and granular layers stained, but cells 
in the horny layer did not (Fig Ib). 
In addition to ChAT, keratinocytes in both tissue culture and skin 
sections contained AChE. AChE immunoreactivity was predomi-
nantly observed in the vicinity of cell membranes. Anti-AChE anti-
bodies also stained intercellular filament bundles (Fig le). Among 
the AChE-positive epidermal basal, spinous, and granular cell 
layers, the former stained most intensively (Fig Id). 
The anti-AChE MoAb did not stain a keratin epitope, as judged 
by the absence of staining in western blots utilizing a panel of 
human epidermal keratins (Sigma; catalogue number K-0253; lot 
number 41H0308) as an antigenic substrate, and mouse anti-cyto-
keratin AE1/ AE3 MoAbs (BioGenex, San Ramon, CA) as positive 
controls. The immunoblotting experiments showed that the anti-
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Figure 1. Immunohistochemical visualization of keratinocyte cholinergic 
enzymes. The ChAT immunoreactivity is seen in the cytoplasm of cultured 
human keratinocytes (a) and throughout normal human epidennis (b) . Tis-
sue culture slides were counterstained with Mayer's hematoxylin to high-
light cell morphology. The AChE immunoreactivity is localized on or near 
the cell membrane of cultured keratinocytes (e) , and in normal human epider-
mis (d) . Negative controls included replacing the lirst-layer anti-ChAT or 
anti-AChE monoclonal antibodies with i) normal rabbit semm (not shown) 
and ii) isotypc (mouse JgG l) matching anti-CD3 monoclonal antibodies 
(e,f ). a,b,e, bar, 20 J.lm; b, bar, 65 J.lm; d,J, bar, 50 J.lm. 
AChE MoAb does recognize a membrane-bound form of human 
AChE (type XIII; Sigma; catalogue number C-5400; lot number 
81H9333) (not shown). 
The specificity of keratinocyte label ing with ChAT and AChE 
was also confirmed by the absence of staining in cell culture and skin 
specimens treated with the isotype, i. e., IgG 1, matching mouse 
anti-CD3 antibodies (Fig 1 e,J) , and in specimens treated with rab-
bit serum instead of the first layer MoAb (not shown). 
Activity of Keratinocyte ChAT The enzymatic activity of ke-
ratinocyte ChAT was detected by the conversion of (3H}AcCoA 
into PH]ACh. The maximum rate (Vmax) of the synthesis of la-
beled ACh in disrupted keratinocytes at 37 D C was about 20 pmoles 
ACh produced/mg protein/min, and the calculated Michaelis-
Menten constant (Krn) was about 9 ,uM (Fig 2a). N ewly synthesized 
[3H]ACh was detected both in cell homogellates and in the chasing 
media from keratinocyte monolayers fed With [3H]AcCoA (Fig 2b) . 
The mean rates of ACh synthesis and release by a single cell were 
estimated to be 2 X 10- 17 mol/min and 7 X 10- 19 mol/min, respec-
tively. The presence of newly synthesized [3H]ACh in both cell 
homogenates and culture supernatants was confirmed by TLC using 
purchased [3HjACh and (3H]AcCoA as external standards (Fig 2c). 
As seen in the graph, the TLC profile of radioactivity in the cell 
homogenate and chasing medium samples corresponded to that of 
the standard [3H}AC h preparation, whereas the radioactivity peak 
of incubation buffer corresponded to [3H]AcCoA. 
AChE decreased the radioactivity of cell homogenates and chas-
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ing media to the blank levels in the radioenzymatic assay (Fig 2b) , 
and eliminated the radioactivi ty peaks of authentic and endoge-
nously synthesized [3H]ACh in the TLC assay (Fig 2c). 
Activity ofKeratinocyte AChE AChE activity was detected in 
both cell homogenates and culture supernatants. The levels of 
AChE were similar, i.e., 1.13 ± 0.15 U/mg protein in cell homo-
genates and 1.24 ± 0.2 U /mg protein in culture supernatants (p > 
0.05) . If the cultures were incubated in the presence of 0.5 mM 
eserine, the AChE activity disappeared. 
DISCUSSION 
ACh is synthesized from AcCoA and choline by the specific cholin-
ergic enzyme ChAT. To inactivate ACh, another enzyme, AChE, 
hydrolyzes it to acetate and choline. In addition to its role as a 
mediator of the parasympathetic neurotransmission, ACh is in-
volved in memory, skeletal and smooth muscle contraction/relax-
ation, heart activity, glandular secretion, and cell division, adher-
ence and motility [6 -10]. In the skin, ACh regulates eccrine sweat 
gland secretion [11] , pigmentation [12] , blood flow [13], vascular 
permeability [14], and mast cell activity [15] . The presence of ex-
traneural ACh in human blood vessel endothelium [16) , parotid 
gland epithelium [17]. small intestine mucosa [18]. sperm [19], and 
now human keratinocytes suggests that it may have a biologic role. 
A cholinergic, non-synaptic system for chemical transmission has 
been recently demonstrated in the skin of the squid Lolligu tlcula 
brevis [20]' and, earlier, ill the tube feet of starfish [21]. Although the 
source and metabolic pathways of the squid skin ACh remained , 
unspecified, it was demonstrated that ACh regulates the optical 
properties of active iridophores in the dermis [22] . 
In humans, ACh acts on target cells via specific nicotinic and 
muscarinic receptors. Nicotinic ACh receptors are expressed in 
neuro-muscular junctions. mAChR are expressed on the cell sur- , 
faces of a variety of non-neuronal cel l types. Some of them, e.g., 
fibroblasts, express mAChR in high density (i.e. , 2 X 105 recep-
tors/cell) [23] , whereas others, e.g., lymphocytes, express only 6 X 
103 receptors per cell [24}. Upon activation by ACh, mAChR regu-
late the metabolism of cyclic AMP, cyclic GMP, phosphatidyl 
inositol, calcium and eicosanoids, and ion (potassium, calcium, chlo-
ride) channel functions [25 ,26]. These same messenger molecules 
regulate keratinocyte proliferation, differentiation, adherence, and 
migration [27 - 30]. Different mAChR subtypes are coupled by dif~ 
ferent G proteins. These ei ther inhibit adenylyl cyclase (i.e., GI 
proteins) or activate phospholipase C (i.e., Gp proteins). There are 
at least five molecular and three pharmacologic subtypes of musca-
rinic receptors (31]. 
We have previously found mAChR in human keratinocytes, and 
shown that these receptors mediate specific effects of ACh on kerati-
nocyte cell-cell adherence. The mean number of mAChR expressed 
by a single keratinocyte is 2.5 X 105, as judged by Scatchard analysis 
of specific binding of the non-selective high-affinity muscarinic 
ligand (3H]atropine to intact cultured human keratinocytes at ODe 
[1] . The molecular and pharmacologic subtypes of mAChR ex-
pressed by keratinocytes remain to be determined. The present 
study describes the other functional elements of the keratinocyte 
cholinergic system. Human keratinocytes appeared to contain 
ChAT to synthesize ACh, and AChE to degrade it. 
ChAT was found in both human keratinocyte cultures and nor-
mal human epidermis. Its immunoreactivi ty was confined to the \ 
perinuclear area of keratinocyte cytoplasm. Keratinocyte ChAT 
synthesizes about 20 pmol ACh/mg protein/min at 37°C. The 
localization and kinetic parameters of keratinocyte ChAT are con-
sistent with those reported for this enzyme from other cell systems. 
For example, ChAT is localized in the vicinity of cell nucleus of 
endothelial cell, apparently in the mitochondria [32] . The activity 
of ChAT in retinas ranges from 8 to 330 pmoles ACh produced/mg 
protein/min, and the reported Krn values for AcCoA for the en-
zyme, obtained from neural and non-neural tissues vary from 6 to 
72,uM [33 -35]. 
W e also found AChE in keratinocyte cultures and normal epider-
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Figure 2. ACh synthesis and release by cultured human keratinocytes. (a) The rate of ACh synthesis by keratinocyte ChAT. The results from a representative 
experiment utilized homogenized 3 X 10· second-passage keratinocytes as the source of the enzyme. Abscissa: AcCoA concentrations in mM (with 
[3HjAcCoA present as 1/50 of the total AcCoA added). Ordinate: rate of reaction, i.e., pmol ACh produced/mg protein/min. The calculated maximum rate 
(V max) was about 20 pmol ACh produced/mg protein/min, and the Michaelis-Menten constant (Km) occurred at a concentration of9.1 tIM (inset) . Error bars, 
SO of the data. (b) The amounts of newly synthesized [3HjACh in cell homogenates and chasing media. The amounts of radioactivity extracted from 
keratinocyte homogenates or the chasing media covering keratinocyte monolayers in the presence of eserine ~ significantly (p < 0.05) exceed the amount of 
radioactivity extracted from control samples containing incubation buffer/KRB (0). The differences in measured radioactivity represent newly synthesized 
[3HjACh. This is proved by a decrease of the radioactivity in samples containing AChE instead of eserine ~ to the blank levels. Newly synthesized [3HjACh 
was degraded by AChE to the non-extractable catabolites. Error bars, SO of three independent experiments. (c) TLC with authentic (lH]ACh and [3H]AcCoA as 
external standards. The radioactivity peaks in experimental samples containing cell homogenate (0) or chasing medium ~ correspond to [3H]ACh (~), 
whereas the radioactivity peak of control sample containing incubation buffer (e) corresponds to [3H]AcCoA (0). Each fraction represents the radioactivity of a 
single piece of silica gel removed from the TLC plates starting at the load point. If the samples were pre-incubated with AChE, most of the radioactivity of 
au thentic [3HJACh, cell homogenate, and chasing medium moved to fraction 8, which apparently represents the location of [3HJacetyi covalently bound to 
AChE, the intermediate product of the reaction of enzymatic degradation of [3HJACh by AChE. Up to 20% total radioactivity, apparently carried by 
subsequent products of the reaction, moved to the last 38-56 fractions (not shown). 
mis. In cell cultures, AChE was localized in or near cell membranes, 
and appeared to be associated with intercellular filament bundles. 
AChE in other types of non-neuronal cells, such as myocytes, hepa-
cocytes, and a variety of hemopoietic cells, is also associated with the 
cell surfaces [36,37]. In epidermis, all living layers exhibited AChE 
immunoreactivity, but the basal cell layer stained more intensively. 
AChE is present in melanocytes as well [12]. Anti-AChE antibodies 
did not stain dermis. Although cholinesterase activity has been pre-
viously reported in human dermis [38], that study measured the 
activity of pseudocholinesterase but not true (i.e., AChE) cholines-
terase. 
Because keratinocyte AChE activity was detected not only in cell 
homogenates, but also in culture supernatants, keratinocytes appar-
ently secrete AChE. The ability of neuronal and non-neuronal cells 
to secrete AChE has been demonstrated previously [39]. It was sug-
gested that, by controlling ACh in non-neural tissues, AChE modu-
lates cell-to-cell communication by mechanisms similar to neuro-
transmission [40]. 
Because ACh is usually associated with neural tissues, the pres-
ence of ACh in keratinocytes suggests a possible relationship with 
neuronal cells, which, like keratinocytes, are of ectodermal origin. 
On the one hand, keratinocytes produce nerve-growth factor [41] 
responsible for the maintenance, development, and differentiation 
of cholinergic neurons, including their abilities to synthesize ACh 
in culture [42]. On the other hand, proliferation of cultured kerati-
nocytes can be stimulated by a product of neuronal cells, vasoactive 
intestinal polypeptide [43], that co-exists with ACh in parasympa-
thetic nerves [44J, and by a product of neuroendocrine cells in bo-
vine pituitary extract [45]. Both keratinocytes and neuronal cells 
metabolize the same mediators, such as ACh, epinephrine [46], and 
enkephalins [47]. 
Bovine pituitary extract may conceivably contain "neural" sub-
stances such as ACh and cholinergic enzymes. Its composition is 
unknown. We used bovine pituitary extract to grow keratinocytes, 
but it did not affect the results of this study because 1) keratinocyte 
CllA T and AChE were visualized in frozen sections of human epi-
dermis and 2) the activities of these enzymes were measured using 
KRB, which did not contain hormones, growth factors, and bovine 
pituitary extract. 
Thus, this study provides evidence that human keratinocytes 
contain ChAT and AChE, and that these cells can synthesize, store, 
secrete, and degrade ACh. Because we have previously demon-
strated that keratinocytes express specific receptors for ACh and that 
ACh can affect cell-cell attachment [1], we suggest that ACh acts as 
a regulatory autocrine/paracrine mediator. Because changes in ACh 
metabolism have been found in skin lesions of various dermatologic 
patients [12,48 - 51], it is conceivable that perturbations of the kerat-
inocyte cholinergic system may be involved in skin diseases, and 
drugs influencing this system may be useful in treating them. 
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